Holen Sie sich die Stockscreener-App
4.55
17.27%
0.67
Handel nachbörslich:
4.64
0.09
+1.98%
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
Institutional scanner results for TriSalus Life Sciences Inc. Equity WarrantQuarterly Market Review & Real-Time Volume Trigger Notifications - Newser
Candlestick signals on TriSalus Life Sciences Inc. stock todayWeekly Gains Report & Entry Point Strategy Guides - Newser
TriSalus Life Sciences Inc. Equity Warrant stock trend outlook and recovery pathWeekly Gains Summary & Safe Entry Point Identification - Newser
Will earnings trigger a reversal in TriSalus Life Sciences Inc.Global Markets & Free High Return Stock Watch Alerts - Newser
TriSalus Life Sciences Inc. Charts Flash Early Recovery SignalsMarket Sentiment Summary & High Win Rate Trade Tips - newsyoung.net
Technical Models Suggest TriSalus Life Sciences Inc. May Rebound SoonJuly 2025 Intraday Action & Safe Capital Growth Tips - sundaytimes.kr
What moving averages say about TriSalus Life Sciences Inc.2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
How to build a custom watchlist for TriSalus Life Sciences Inc.Sell Signal & Reliable Price Action Trade Plans - Newser
Volatility clustering patterns for TriSalus Life Sciences Inc. Equity WarrantEarnings Performance Report & Real-Time Stock Entry Alerts - Newser
How TriSalus Life Sciences Inc. stock performs during market volatilityInflation Watch & Fast Entry Momentum Alerts - Newser
Can TriSalus Life Sciences Inc. Equity Warrant rally from current levelsMarket Movement Recap & Verified Technical Signals - Newser
Understanding TriSalus Life Sciences Inc. Equity Warrant’s price movementEarnings Recap Report & AI Forecast Swing Trade Picks - Newser
TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs - MSN
When is the best time to exit TriSalus Life Sciences Inc. Equity WarrantTreasury Yields & Free Real-Time Volume Trigger Notifications - Newser
Is TriSalus Life Sciences Inc. Equity Warrant Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Using RSI to spot recovery in TriSalus Life Sciences Inc.Entry Point & Long-Term Safe Investment Plans - Newser
Applying big data sentiment scoring on TriSalus Life Sciences Inc. Equity WarrantGold Moves & Technical Entry and Exit Tips - Newser
Sector ETF performance correlation with TriSalus Life Sciences Inc.July 2025 Technicals & Smart Allocation Stock Tips - Newser
Is TriSalus Life Sciences Inc. Equity Warrant Stock a Good Fit for Conservative InvestorsChart Signals & Smart Money Movement Tracker - Newser
Will TriSalus Life Sciences Inc. see short term momentumMarket Rally & High Conviction Buy Zone Alerts - Newser
Applying Wyckoff theory to TriSalus Life Sciences Inc. stockQuarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
TriSalus Life Sciences Reports Strong Growth Amid Challenges - TipRanks
Top chart patterns to watch in TriSalus Life Sciences Inc.Portfolio Update Summary & Risk Managed Trade Strategies - Newser
What technical models suggest about TriSalus Life Sciences Inc.’s comebackEarnings Performance Report & Capital Efficiency Focused Ideas - Newser
Published on: 2025-08-13 06:48:48 - Newser
Will TriSalus Life Sciences Inc. price bounce be sustainableTrade Risk Assessment & Growth Oriented Trading Recommendations - Newser
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates - MSN
Tick level data insight on TriSalus Life Sciences Inc. Equity Warrant volatility2025 Geopolitical Influence & Verified Momentum Stock Alerts - Newser
Using economic indicators to assess TriSalus Life Sciences Inc. Equity Warrant potential - Newser
TriSalus Life Sciences Inc (TLSI) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
Using RSI to spot recovery in TriSalus Life Sciences Inc. Equity WarrantFree AI Based High Gain Watchlist Scanner - Newser
TriSalus Life Sciences Reports Strong Q2 2025 Growth - TipRanks
What makes TriSalus Life Sciences Inc. Equity Warrant stock price move sharplyInvestment Roadmap for High Potential Stocks - Newser
How to read the order book for TriSalus Life Sciences Inc.Secure Entry Point Finder with Analysis - Newser
Earnings call transcript: TriSalus Life Sciences Q2 2025 sees strong revenue growth - Investing.com Nigeria
TriSalus Life Sciences Q2 rev. up 52% YoY to $11.2mln. - AInvest
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance - Bluefield Daily Telegraph
Analyzing recovery setups for TriSalus Life Sciences Inc. investorsSteady Return Plan Based on Data Analysis - Newser
Can trapped investors hope for a rebound in TriSalus Life Sciences Inc.Free Reliable Alerts for Daily Stock Movers - Newser
How TriSalus Life Sciences Inc. Equity Warrant stock performs during market volatilityWealth Accumulation Outlook for Safe Investors - Newser
Chart based analysis of TriSalus Life Sciences Inc. Equity Warrant trendsConservative Investment Setup and Risk Analysis - Newser
Chart based exit strategy for TriSalus Life Sciences Inc. Equity WarrantHigh Win Rate Strategy with Stop Protection - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.Portfolio Review Summary with Five-Year Outlook - Newser
Detecting support and resistance levels for TriSalus Life Sciences Inc.Momentum Trading Guide with Safety Limits - Newser
Quant Strategy Flags TriSalus Life Sciences Inc. for EntryStock Market Watch With Alerts Shows Unusual Activity - beatles.ru
TriSalus study shows promising results for thyroid disease treatment - Investing.com
Breakthrough Thyroid Procedure Achieves 73% Size Reduction: New Clinical Data Reveals Game-Changing Results - Stock Titan
Is TriSalus Life Sciences Inc. Equity Warrant stock entering bullish territoryDaily Upside Movement Prediction With Data - Newser
Why TriSalus Life Sciences Inc. stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):